From Specialty Pharmacy News - It’s not only the United States that’s seeing costs to treat cancer continue to rise. Last year the cost of cancer drugs and supportive therapies totaled $107 billion globally, an 11.5% increase in constant dollars from 2014, according to a new report from the IMS Institute for Healthcare Informatics. That’s up from an annual cost growth rate of 3.8% in 2011, according to the report, titled Global Oncology Trend Report: A Review of 2015 and Outlook to 2020. In the U.S., the annual growth rate for cancer drug costs rose from 2.0% in 2011 to 13.9% last year. Read more
From Drug Benefit News - As the roles of retail pharmacies are set to transform, PBMs can capitalize on their own capabilities and collaborate with pharmacies, as well as other stakeholders, in a variety of ways. Pharmacies, maintains a recently released report, have the opportunity to offer a wide array of services from which consumers can pick and choose. This could be done through broadening their own offerings, as well as collaborating with other health… Read more
From Specialty Pharmacy News - Blue Cross and Blue Shield of New Mexico earlier this year launched an oncology medical home pilot that the payer says it expects will decrease emergency room and urgent care visits, as well as hospitalizations. Keeping members in their own homes while they are undergoing care is one of the main gains, which can help them both physically and psychologically, improving their overall care. Read more
Check out all of the benefits, sample issues & more!